Dr. Jeff Ratliff talks with Dr. Jason Margolesky about the frequency of blepharoclonus in Parkinson disease and atypical Parkinsonian disorders to explore whether this clinical phenomenology may be useful in the evaluation and diagnosis of patients…
Read MoreDr. Matt Barrett talks with Drs. Julie A. Schneider and Sonal Agrawal about whether Lewy body and cerebrovascular pathologies act synergistically to increase the severity of parkinsonism beyond their separate effects. Read the related article in ….
Read MoreThe June 2023 replay of past episodes showcases a selection of interviews regarding the biomarker discovery in Parkinson disease. This episode begins with an overview of the latest in Parkinson’s research, including biomarker development with Dr….
Read MoreDr. Jeff Ratliff talks with Prof. Andrew Siderowf about the assessment of heterogeneity among participants in the Parkinson progression markers initiative cohort using α-synuclein seed amplification. Read the related article in . Disclosures can be…
Read MoreDr. Jason Crowell talks with Prof. Bastiaan Bloem about the latest developments in biomarkers and treatments for movement disorders, which have been described in numerous research papers from 2022. Read the related article in . Disclosures can…
Read MoreDr. Jason Crowell talks with Dr. Sophie Cho, Program Director in the Division of Clinical Research at NINDS, about the state of Parkinson disease research. For links to previous podcast episodes, please visit . Disclosures can be found at .
Read MoreDr. Jeff Ratliff talks with Dr. Raúl Martínez-Fernández about the long-term outcome of unilateral FUS-STN treatment for Parkinson disease. Read the related article in . Disclosures can be found at .
Read More
Comentarios recientes